Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZL38
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,785.80 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/mL auto-injector units. The award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a specific product delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, competing on its established capabilities within the federal pharmaceutical supply chain.
This delivery order falls under DMS Pharmaceutical Group's significant $499.999 billion IDC with the Defense Logistics Agency under the SPE2DB program, which remains valid through November 2026. The contract vehicle enables DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and specialty auto-injectors such as Nucala, to support Department of Defense healthcare facilities worldwide. As a cornerstone supplier of pharmaceutical products to military health systems, DMS Pharmaceutical Group leverages its extensive product portfolio and established federal procurement experience to fulfill critical medical supply requirements across the DoD healthcare network.
Quick answers
Who was awarded contract SPE2DB25FZL38?
SPE2DB25FZL38 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FZL38 worth?
The government has obligated $3,786 on SPE2DB25FZL38.
Is contract SPE2DB25FZL38 an order under another contract?
Yes. SPE2DB25FZL38 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL38 competed?
The extent of competition for SPE2DB25FZL38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award